20-2816588-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001167670.3(TMEM239):āc.34A>Gā(p.Ile12Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000217 in 1,384,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001167670.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM239 | NM_001167670.3 | c.34A>G | p.Ile12Val | missense_variant | 2/2 | ENST00000380585.2 | NP_001161142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM239 | ENST00000380585.2 | c.34A>G | p.Ile12Val | missense_variant | 2/2 | 1 | NM_001167670.3 | ENSP00000369959 | P1 | |
TMEM239 | ENST00000361033.1 | c.163A>G | p.Ile55Val | missense_variant | 2/2 | 2 | ENSP00000354312 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000714 AC: 1AN: 140040Hom.: 0 AF XY: 0.0000132 AC XY: 1AN XY: 75532
GnomAD4 exome AF: 0.00000217 AC: 3AN: 1384878Hom.: 0 Cov.: 37 AF XY: 0.00000293 AC XY: 2AN XY: 683380
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2023 | The c.34A>G (p.I12V) alteration is located in exon 2 (coding exon 1) of the TMEM239 gene. This alteration results from a A to G substitution at nucleotide position 34, causing the isoleucine (I) at amino acid position 12 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at